STAT3 and lung cancer: Signal transducer and activator of transcription 3 (STAT3), a vital prooncogenic transcription factor in multiple cancers [17–19], is constitutively activated in approximately 50% of NSCLC primary tumors and lung cancer-derived cell lines and may be one of the most important oncogenic drivers in NSCLC [11, 20].